Company & leadership overview

AegisOne Technologies, Inc. is the corporate home of the AegisOne Home Health Hub and the AegisOne Intelligence Layer behind it. The company's focus is simple: bring sophisticated diagnostics and connected-care workflows into the home, and make the resulting data usable by telehealth, providers, and insurers without adding friction for patients.

The Hub is designed to run common tests (COVID, flu, strep, UTI, pregnancy, ovulation, glucose, lipids, thyroid, hormones and more) plus core vitals and wound/skin capture, while the backend ecosystem handles telehealth routing, provider/EHR handoff, and insurance-ready reporting.

AegisOne Technologies, Inc. is formed as a Delaware C-Corporation with clean ownership and vesting. The existing Wisconsin LLC is planned to be merged into the Delaware entity so that all IP and operations sit under a single, acquirer-friendly structure.

• Delaware C-Corp as the primary corporate entity.
• Founder majority ownership (~90%) with vesting configured.
• Wisconsin LLC to be merged into the Delaware corporation.
• Designed to make IP assignment and acquisition documentation straightforward.

As Founder and CEO of AegisOne Technologies, Inc., Bryan is responsible for overall company direction: defining the Home Health Hub vision, shaping the product roadmap, and aligning the ecosystem with the realities of providers, telehealth platforms, and payers.

Bryan focuses on where the AegisOne Home Health Hub fits into existing care and reimbursement models: which diagnostics matter most at home, what data clinicians and insurers actually need, and how the system should behave so it can be acquired and scaled by a larger organization without being brittle.

In addition to serving as CEO, Bryan currently holds interim responsibility for product, technology, and integration strategy. This reflects the company's early stage and is not intended as a permanent structure once the platform is acquired or scaled.

On the product and technology side, Bryan defines how the countertop Hub, cartridges, and AegisOne Intelligence Layer interact: what runs on-device vs. in the cloud, how results are scored and routed, and how providers and insurers see those results.

On the integration side, he focuses on how AegisOne connects to telehealth clinicians, existing providers, EHR systems, and payers, with an emphasis on clean handoff to an acquirer's preferred stack and standards. These responsibilities can be transitioned to dedicated leaders within an acquiring organization.

Stephanie Thacker serves as a Clinical Advisor to AegisOne, bringing grounded clinical experience and a practical view of how home diagnostics and telehealth workflows show up in real patient journeys. Her background spans direct patient care and coordination across different care settings.

For the AegisOne Home Health Hub, Stephanie's input focuses on how tests and vitals should be presented, which flows are realistic for families at home, and where clinical safety guardrails are most critical when routing results to telehealth or in-person follow-up.

Clinical advisory work helps ensure that the AegisOne ecosystem reflects real-world clinical constraints rather than hypothetical scenarios. That includes:

• Identifying where home diagnostics support — or conflict with — existing clinical workflows.
• Guiding how results and vitals should be summarized so they are useful for clinicians, not overwhelming.
• Highlighting edge cases and safety concerns when families rely on at-home tests prior to escalation.

This perspective is especially important as more diagnostics move into the home, and as telehealth and payers adapt their policies around at-home testing and monitoring.

For investors, AegisOne Technologies, Inc. offers a majority founder-owned entity with clearly defined responsibilities and a tight focus on the Home Health Hub ecosystem. The structure makes it straightforward to understand who owns what, how decisions are made, and how roles can evolve with additional capital.

• Majority founder ownership (approximately 90%) with vesting in place.
• Clear mapping of responsibilities across product, technology, integrations, and clinical advisory.
• Corporate documentation organized to support due diligence and future rounds.

For potential acquirers, AegisOne is intentionally structured so the AegisOne Home Health Hub can be integrated into an existing device, virtual care, or payer-focused portfolio with minimal friction.

• Clean Delaware C-Corp entity with consolidatable IP (including LLC merge and IP assignment plans).
• Architecture and leadership roles that map cleanly into common product, engineering, and clinical orgs.
• Room for acquirers to rebrand, extend test menus, and plug into their preferred telehealth and EHR stacks.